Department of Radiation Oncology, American University of Beirut Medical Center, Beirut, Lebanon.
Radiat Oncol. 2011 May 13;6:46. doi: 10.1186/1748-717X-6-46.
Thyroid associated orbitopathy is a common manifestation of Graves disease. Many options can be considered for treatment. In this case series, we reviewed the medical records of 17 patients who received radiation therapy (RT) for GO in a tertiary care center between 1997 and 2007. All patients received 20 Gy to both orbits and 12 of them (71%) had already received one or more trials of steroid therapy prior to RT. After a median follow-up of 2 years, a subjective improvement in exophthalmos and vision was reported by all patients at the end of RT but only 3 patients reported a decrease in their diplopia immediately after therapy. Symptoms continued to improve with time in many patients: 22% had complete reversal of their symptoms and signs, and the remaining 78% had partial improvement. Two patients developed recurrent signs and symptoms, both of them were smokers who continued to smoke after treatment. About 60-65% of patients responded favorably to RT alone which increased to 87-97% when RT is combined with steroids. No patients developed late toxicity during the follow-up period. We conclude that RT is an effective treatment option in GO even in patients who failed previous treatment with steroids or surgical decompression. Based on our own clinical experiences and the literature data, the combination of RT and intravenous corticosteroid administration may improve the response rate.
甲状腺相关眼病是 Graves 病的常见表现。有许多治疗选择可供考虑。在本病例系列中,我们回顾了 1997 年至 2007 年间在一家三级保健中心接受放射治疗 (RT) 治疗 GO 的 17 例患者的病历。所有患者的双眼均接受 20 Gy 的照射,其中 12 例(71%)在 RT 前已接受过一次或多次类固醇治疗试验。中位随访 2 年后,所有患者在 RT 结束时均报告眼球突出和视力有主观改善,但只有 3 例患者在治疗后立即报告复视减轻。许多患者的症状随时间继续改善:22%的患者症状和体征完全逆转,其余 78%的患者有部分改善。有 2 例患者出现复发症状和体征,均为治疗后继续吸烟的吸烟者。约 60-65%的患者单独接受 RT 治疗反应良好,而 RT 联合类固醇治疗的反应率增加到 87-97%。在随访期间,没有患者发生晚期毒性。我们的结论是,即使在先前接受类固醇或手术减压治疗失败的患者中,RT 也是 GO 的有效治疗选择。基于我们自己的临床经验和文献数据,RT 联合静脉内皮质类固醇给药可能会提高反应率。